The Pharmacogenefics Research Network (PGRN) has matured to the point that there are now numerous network activities, such that an administrative support structure for the network is needed. Many of the PGRN Logistics Resource functions described herein have been historically handled by the PGRN Program Director (Dr. Rochelle Long), commercial meeting planners, or the PharmGKB. With the increased activities of the PGRN, it is unrealistic and an inefficient use of the Dr. Long's scientific expertise to have her and her office serve the network in so many administrative capacifies. Additionally, the PharmGKB has historically been funded under the PGRN, and one of its functions has been to provide the PGRN with a website. However, the PharmGKB will now be funded under a separate RFA and will no longer be part of the PGRN. As such, a PGRN website is needed. Finally, the PGRN holds twice annual scientific meetings, along with face to face Steering Committee meetings, and organization of these meetings could be more efficiently handled through a central PGRN administrafive site than through the current process of government bidding and contracting of meefing planners. Thus, the network is in crifical need of a network resource that would provide logistics infrastructure to the network and its activities.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-GGG-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Florida
United States
Zip Code
Del-Aguila, J L; Cooper-DeHoff, R M; Chapman, A B et al. (2015) Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazide. Pharmacogenomics J 15:153-7
Smith, Steven M; Gong, Yan; Handberg, Eileen et al. (2014) Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. J Hypertens 32:635-43
Barrie, Elizabeth S; Weinshenker, David; Verma, Anurag et al. (2014) Regulatory polymorphisms in human DBH affect peripheral gene expression and sympathetic activity. Circ Res 115:1017-25
Daneshjou, Roxana; Gamazon, Eric R; Burkley, Ben et al. (2014) Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans. Blood 124:2298-305
Owusu-Obeng, Aniwaa; Weitzel, Kristin W; Hatton, Randy C et al. (2014) Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy 34:1102-12
Chapman, Arlene B; Cotsonis, George; Parekh, Vishal et al. (2014) Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension. Am J Hypertens 27:546-54
Del-Aguila, J L; Beitelshees, A L; Cooper-Dehoff, R M et al. (2014) Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans. Pharmacogenomics J 14:35-40
Yoneyama, Sachiko; Guo, Yiran; Lanktree, Matthew B et al. (2014) Gene-centric meta-analyses for central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations. Hum Mol Genet 23:2498-510
Fontana, Vanessa; McDonough, Caitrin W; Gong, Yan et al. (2014) Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension. J Am Heart Assoc 3:e001398
Karnes, Jason H; Gong, Yan; Arwood, Meghan J et al. (2014) Alteration in fasting glucose after prolonged treatment with a thiazide diuretic. Diabetes Res Clin Pract 104:363-9

Showing the most recent 10 out of 83 publications